Regeneron Pharmaceuticals (REGN) Dividend Coverage Ratio Growth (1y) (2026)
Analysis
Regeneron Pharmaceuticals (REGN) Dividend Coverage Ratio Growth (1y) (2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.51 Bn | 77.52 Bn | 3.93 Bn | -10.85% |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.83 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.33 Bn | 32.03 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.36 Bn | 27.52 Bn | - | -1.84% |
| 9 | Insmed | 27.43 Bn | 26.27 Bn | 358.27 Mn | - |
| 10 | Incyte | 25.63 Bn | 21.09 Bn | 1.57 Bn | - |